Market Cap 217.03B
Revenue (ttm) 41.95B
Net Income (ttm) 13.40B
EPS (ttm) N/A
PE Ratio 24.96
Forward PE 24.19
Profit Margin 31.95%
Debt to Equity Ratio 0.25
Volume 1,632,200
Avg Vol 6,519,576
Day's Range N/A - N/A
Shares Out 1.74B
Stochastic %K 28%
Beta 0.72
Analysts Strong Sell
Price Target $146.69

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement th...

Industry: Medical Devices
Sector: Healthcare
Phone: 224 667 6100
Address:
100 Abbott Park Road, Abbott Park, North Chicago, United States
1iquid
1iquid Dec. 26 at 6:33 AM
💎 Liquid® Live Actionable Trade Asset: $ABT Contracts: $ABT January 15, 2027 $130 Calls Scale in: $9.38- $11.47 Scale out: $36.49-$62.55 Profit Potential : 216% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 25 at 9:59 PM
$ABT Current Stock Price: $125.08 Contracts to trade: $125 ABT Dec 26 2025 Call Entry: $0.32 Exit: $0.53 ROI: 67% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Audreyknight
Audreyknight Dec. 25 at 3:30 PM
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 1:22 PM
Actionable Trade Alert for $ABT: Market Context: $ABT is currently trading at $124.81, showing a neutral RSI of 48.18, indicating no immediate overbought or oversold conditions. The stock is positioned between its 60D high of $135.45 and low of $120.7, suggesting potential for movement within this range. Directional Bias: With the current price below the 30-day (126.38) and 50-day (126.4) moving averages, there is a slight bearish sentiment. However, the proximity to the 60D low could provide a bounce opportunity. Trade Plan: - Suggested Entry: $124.81 - Stop Loss: $120.00 (below the 60D low) - Take Profit Targets: 1. $128.00 (3.5% ROI) 2. $132.00 (5.8% ROI) 3. $146.00 (17% ROI) This plan offers a solid risk-reward ratio, targeting significant upside while maintaining a manageable stop loss. Monitor price action closely for entry confirmation. https://privateprofiteers.com
0 · Reply
milobo71279
milobo71279 Dec. 24 at 5:23 PM
0 · Reply
Alexisvan
Alexisvan Dec. 24 at 4:43 PM
0 · Reply
BrainChipBets
BrainChipBets Dec. 24 at 3:39 PM
$ABT Capital markets will reward proof that pricing power can persist through normalization phases, with outcomes shaped by timing and discipline. Execution clarity would stabilize long‑term sentiment.
0 · Reply
rubraquercus
rubraquercus Dec. 23 at 9:14 PM
$ABT POS returns
0 · Reply
rubraquercus
rubraquercus Dec. 23 at 8:57 PM
$ABT The worst customer service company ever, the Libre glucose sensor replacement website is a joke and customer service (if they answer) is run out of a 3rd world country. Unreal how they sell billions of these per Q and suck at helping customers
0 · Reply
ZacksResearch
ZacksResearch Dec. 23 at 7:41 PM
$ABT's FDA approval for Volt PFA System is a significant development for AFib treatment! 🚀 🔬 Strong VOLT-AF IDE study results: effective & safe for paroxysmal & persistent AFib 🌍 Expansion plans in the US & EU after earlier CE Mark approval 💹 ABT's earnings yield of 4.1% outpaces industry’s 0.1% See the full story here 👉 https://www.zacks.com/stock/news/2808192/abbott-stock-may-benefit-following-volt-pfas-fda-approval?cid=sm-stocktwits-2-2808192-body-26100&ADID=SYND_STOCKTWITS_TWEET_2_2808192_BODY_26100
0 · Reply
Latest News on ABT
Abbott increases quarterly dividend for 54th consecutive year

Dec 12, 2025, 10:26 AM EST - 13 days ago

Abbott increases quarterly dividend for 54th consecutive year


Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 26 days ago

Best Dividend Aristocrats For December 2025

ABBV ADM ADP AFL ALB AMCR AOS


Abbott to Acquire Exact Sciences for $21 Billion

Nov 20, 2025, 7:46 AM EST - 5 weeks ago

Abbott to Acquire Exact Sciences for $21 Billion

EXAS


10 Defensive Stocks with Market-Beating Yields

Nov 8, 2025, 1:10 PM EST - 6 weeks ago

10 Defensive Stocks with Market-Beating Yields

DG


Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 7 weeks ago

Best Dividend Aristocrats For November 2025

ABBV ADM ADP AMCR AOS ATO BDX


Best Dividend Kings: October 2025

Oct 29, 2025, 5:11 AM EDT - 2 months ago

Best Dividend Kings: October 2025

ABBV ABM ADM ADP AWR BDX BKH


Abbott: GLP-1 Beneficiary - A Dividend Raise May Be Coming

Oct 18, 2025, 9:39 AM EDT - 2 months ago

Abbott: GLP-1 Beneficiary - A Dividend Raise May Be Coming


Gold Gains Over 1%; Abbott Shares Fall After Q3 Results

Oct 15, 2025, 2:20 PM EDT - 2 months ago

Gold Gains Over 1%; Abbott Shares Fall After Q3 Results


Abbott Laboratories (ABT) Q3 2025 Earnings Call Transcript

Oct 15, 2025, 1:36 PM EDT - 2 months ago

Abbott Laboratories (ABT) Q3 2025 Earnings Call Transcript


Abbott Labs Posts Higher Sales, Reaffirms Outlook

Oct 15, 2025, 7:55 AM EDT - 2 months ago

Abbott Labs Posts Higher Sales, Reaffirms Outlook


Best Dividend Aristocrats For October 2025

Sep 28, 2025, 1:00 AM EDT - 3 months ago

Best Dividend Aristocrats For October 2025

ADP ATO BDX BEN CAH CHRW CL


Abbott Hosts Conference Call for Third-Quarter Earnings

Sep 24, 2025, 9:00 AM EDT - 3 months ago

Abbott Hosts Conference Call for Third-Quarter Earnings


Daily Dividend Report: Kroger, TXN, Philip Morris, Abbott, GE

Sep 19, 2025, 2:25 PM EDT - 3 months ago

Daily Dividend Report: Kroger, TXN, Philip Morris, Abbott, GE

GE KR PM


1 Dividend King To Hold And 2 Worth Buying Now

Sep 19, 2025, 12:37 PM EDT - 3 months ago

1 Dividend King To Hold And 2 Worth Buying Now

FRT PPG


Abbott Declares 407th Consecutive Quarterly Dividend

Sep 19, 2025, 9:00 AM EDT - 3 months ago

Abbott Declares 407th Consecutive Quarterly Dividend


Inside Abbott's big bet on the future of healthcare

Sep 6, 2025, 9:01 AM EDT - 3 months ago

Inside Abbott's big bet on the future of healthcare


Abbott CEO reveals the biggest disruptions in healthcare

Aug 27, 2025, 2:30 PM EDT - 4 months ago

Abbott CEO reveals the biggest disruptions in healthcare


Best Dividend Aristocrats For September 2025

Aug 27, 2025, 2:09 PM EDT - 4 months ago

Best Dividend Aristocrats For September 2025

ABBV ADM ADP AFL ALB AMCR AOS


Best Dividend Kings: August 2025

Aug 24, 2025, 10:13 PM EDT - 4 months ago

Best Dividend Kings: August 2025

ABBV ABM ADM AWR BDX BKH CINF


1iquid
1iquid Dec. 26 at 6:33 AM
💎 Liquid® Live Actionable Trade Asset: $ABT Contracts: $ABT January 15, 2027 $130 Calls Scale in: $9.38- $11.47 Scale out: $36.49-$62.55 Profit Potential : 216% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 25 at 9:59 PM
$ABT Current Stock Price: $125.08 Contracts to trade: $125 ABT Dec 26 2025 Call Entry: $0.32 Exit: $0.53 ROI: 67% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Audreyknight
Audreyknight Dec. 25 at 3:30 PM
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 1:22 PM
Actionable Trade Alert for $ABT: Market Context: $ABT is currently trading at $124.81, showing a neutral RSI of 48.18, indicating no immediate overbought or oversold conditions. The stock is positioned between its 60D high of $135.45 and low of $120.7, suggesting potential for movement within this range. Directional Bias: With the current price below the 30-day (126.38) and 50-day (126.4) moving averages, there is a slight bearish sentiment. However, the proximity to the 60D low could provide a bounce opportunity. Trade Plan: - Suggested Entry: $124.81 - Stop Loss: $120.00 (below the 60D low) - Take Profit Targets: 1. $128.00 (3.5% ROI) 2. $132.00 (5.8% ROI) 3. $146.00 (17% ROI) This plan offers a solid risk-reward ratio, targeting significant upside while maintaining a manageable stop loss. Monitor price action closely for entry confirmation. https://privateprofiteers.com
0 · Reply
milobo71279
milobo71279 Dec. 24 at 5:23 PM
0 · Reply
Alexisvan
Alexisvan Dec. 24 at 4:43 PM
0 · Reply
BrainChipBets
BrainChipBets Dec. 24 at 3:39 PM
$ABT Capital markets will reward proof that pricing power can persist through normalization phases, with outcomes shaped by timing and discipline. Execution clarity would stabilize long‑term sentiment.
0 · Reply
rubraquercus
rubraquercus Dec. 23 at 9:14 PM
$ABT POS returns
0 · Reply
rubraquercus
rubraquercus Dec. 23 at 8:57 PM
$ABT The worst customer service company ever, the Libre glucose sensor replacement website is a joke and customer service (if they answer) is run out of a 3rd world country. Unreal how they sell billions of these per Q and suck at helping customers
0 · Reply
ZacksResearch
ZacksResearch Dec. 23 at 7:41 PM
$ABT's FDA approval for Volt PFA System is a significant development for AFib treatment! 🚀 🔬 Strong VOLT-AF IDE study results: effective & safe for paroxysmal & persistent AFib 🌍 Expansion plans in the US & EU after earlier CE Mark approval 💹 ABT's earnings yield of 4.1% outpaces industry’s 0.1% See the full story here 👉 https://www.zacks.com/stock/news/2808192/abbott-stock-may-benefit-following-volt-pfas-fda-approval?cid=sm-stocktwits-2-2808192-body-26100&ADID=SYND_STOCKTWITS_TWEET_2_2808192_BODY_26100
0 · Reply
ZacksResearch
ZacksResearch Dec. 23 at 6:41 PM
FDA greenlight could be a quiet catalyst for $ABT 👀 Abbott just won FDA approval for its Volt PFA System for AFib, setting up U.S. launches and supporting EU expansion following earlier CE Mark clearance — a meaningful step forward for its electrophysiology portfolio. See how this approval could benefit Abbott stock 👉 https://www.zacks.com/stock/news/2808192/abbott-stock-may-benefit-following-volt-pfas-fda-approval?cid=sm-stocktwits-2-2808192-teaser-26099&ADID=SYND_STOCKTWITS_TWEET_2_2808192_TEASER_26099
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 22 at 3:55 PM
1 · Reply
SPYmyQQQ
SPYmyQQQ Dec. 22 at 3:03 PM
🚀 New Signal ✅ 🏛️ $ABT 🗓️ Dec 22, 2025 💵 Entry: $126.65 🎯 Target (Opt.): $129.85 (+2.53%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
1iquid
1iquid Dec. 22 at 7:34 AM
💎 Liquid® Live Actionable Trade Asset: $ABT Contracts: $ABT January 15, 2027 $130 Calls Scale in: $9.94- $12.15 Scale out: $38.66-$66.27 Profit Potential : 378% ROI Blended Join 💎 Here: https://1iquid.com
0 · Reply
TalkMarkets
TalkMarkets Dec. 21 at 8:40 PM
#Pharma's $370 Billion #Bet On #America: The #ETF Plays For 2026 $IHE $PJP $PPH Also $ABT $GSK https://talkmarkets.com/content/us-markets/pharmas-370-billion-bet-on-america-the-etf-plays-for-2026?post=546051&userid=123969
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Dec. 21 at 12:16 PM
$ABT monthly. yuge > 140
0 · Reply
equity_research
equity_research Dec. 20 at 10:34 PM
$CSU.TSX $BIP $ABT Chris Blumas' Top Picks: Constellation Software, Brookfield Infrastructure & Abbott Labs https://www.bnnbloomberg.ca/video/shows/market-call/2025/12/17/chris-blumas-top-picks-constellation-software-brookfield-infrastructure-abbott-labs/
0 · Reply
DividendPower
DividendPower Dec. 20 at 12:51 PM
Recent Dividend Increases - Updated 12/20/25 https://www.dividendpower.org/dividend-increases/ $THFF $BEN $ABT $WPC $PNR
0 · Reply
1iquid
1iquid Dec. 20 at 6:43 AM
OptionWizards Tip (education only): Compare the option’s breakeven price to ABT, TMO, or MCD’s recent trading range to assess realistic profit potential. $ABT $TMO $MCD Not financial advice.
0 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 19 at 8:55 PM
Hedge Alert Live - Protect Your Portfolio Contract: $ABT $125.00 Put · DEC 26, 2025 Exp Entry Price: $1.06 - $1.11 Exit Price Target: $2.51 Profit Margin: +137% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 19 at 4:08 PM
0 · Reply
Oldpuck
Oldpuck Dec. 19 at 3:39 PM
$ABT is treading water until these Similac lawsuits are thrown out.
0 · Reply